DOI: 10.3724/SP.J.1264.2011.00023

Chinese Journal of Multiple Organ Diseases in the Elderly (中华老年多器官疾病杂志) 2011/10:4 PP.381-384

Single nucleotide polymorphism and Alzheimer¢s disease

Genetic factors play important roles in the development of Alzheimer¢s disease(AD). We mainly introduced some genes, which has been reported in recent years, predisposing to different aspects of AD. Besides, from the aspects of epigenetics, gene or drug therapy, we also discussed how to block the expression pathway of some predisposing genes, so as to inhibit or delay the development of AD. Except several genes related to familial AD and apolipoprotein E, some other predisposing genes related to sporadic AD remains controversal. Racial diversity and sample size might explain the disagreement of various researches. Therefore, further studies are needed for better diagnosis and gene therapy of AD.

Key words:single nucleotide polymorphism,Alzheimer¢s disease

ReleaseDate:2014-07-21 15:56:28

[1] Hara H, Kataoka S, Anan M, et al. The therapeutic effects of the herbal medicine, Juzen-taiho-to, on amyloid-β burden in a mouse model of Alzheimer¢s disease[J]. J Alz-heimers Dis, 2010, 20(2): 427-439.

[2] Bryleva EY, Rogers MA, Chang CC, et al. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD[J]. Proc Natl Acad Sci USA, 2010, 107(7): 3081-3086.

[3] Tchantchou F, Graves M, Ortiz D, et al. S-adenosyl methionine: A connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer¢s disease[J]. J Nutr Health Aging, 2006, 10(6): 541-544.

[4] Kim HS, Kim EM, Kim NJ, et al. Inhibition of histone deacetylation enhances the neurotoxicity induced by the C-terminal fragments of amyloid precursor protein[J]. J Neurosci Res, 2004, 75(1): 117-124.

[5] Veeraraghavalu K, Choi SH, Sisodia SS. Expression of fa-milial Alzheimer¢s disease-linked human presenilin 1 vari-ants impair enrichment-induced adult hippocampal neuro-genesis[J]. Neurodegener Dis, 2010, 7(1-3): 46-49.

[6] Ryan NS, Rossor MN.Correlating familial Alzheimer¢s disease gene mutations with clinical phenotype[J]. Biomark Med, 2010, 4(1): 99-112.

[7] Avramopoulos D. Genetics of Alzheimer¢s disease: recent advances[J]. Genome Med, 2009, 1(3): 34.

[8] Rebeck GW, Reiter JS, Strickland DK, et al. Apoli-poprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions[J]. Neuron, 1993, 11(4): 575-580.

[9] Poirier J. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer¢s disease[J]. Alzheimers Dement, 2008, 4(1 Suppl 1): S91- S97.

[10] Tycko B, Feng L, Nguyen L, et al. Polymorphisms in the human apolipoprotein-J/clusterin gene:ethnic variation and distribution in Alzheimer’s disease[J]. Hum Genet, 1996, 98(4): 430-436.

[11] Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associ-ated with Alzheimer¢s disease[J]. Nat Genet, 2009, 41(10): 1094-1099.

[12] Harold D, Abraham R, Hollingworth P, et al. Ge-nome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease[J]. Nat Genet. 2009, 41(10): 1088-1093.

[13] Giedraitis V, Kilander L, Degerman-Gunnarsson M, et al. Genetic analysis of Alzheimer¢s disease in the Upp-sala Longitudinal Study of Adult Men[J]. Dement Geriatr Cogn Disord, 2009, 27(1): 59-68.

[14] Nuutinen T, Suuronen T, Kauppinen A, et al. Val-proic acid stimulates clusterin expression in human astro-cytes: Implica- tions for Alzheimer¢s disease[J]. Neurosci Lett, 2010, 475(2): 64-68.

[15] Qing H, He G, Ly PT, et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioural deficits in Alzheimer¢s disease mouse models[J]. J Exp Med, 2008, 205(12): 2781-2789.

[16] Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer¢s risk in APOEε4 carriers[J]. Neu-ron, 2007, 54(5): 713-720.

[17] Li H, Wetten S, Li L, et al. Candidate sin-gle-nucleotide polymorphisms from a genomewide associa-tion study of Alzheimer disease[J]. Arch Neurol, 2008, 65(1): 45-53.

[18] Seshadri S, Fitzpatrick AL, Ikram MA, et al. Ge-nome-wide analysis of genetic loci associated with Alz-heimer¢s disease[J]. JAMA, 2010, 303(18): 1832-1840.

[19] Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer¢s disease[J]. Nat Genet, 2007, 39(2): 168-177.

[20] Tan EK, Lee J Chen CP, et al. SORL1 haplotypes modulate risk of Alzheimer¢s disease in Chinese[J]. Neuro-biol Aging, 2009, 30(7): 1048-1051.

[21] Shibata N, Ohnuma T, Baba H, et al. Genetic asso-ciation between SORL1 polymorphisms and Alzheimer¢s disease in a Japanese population[J]. Dement Geriatr Cogn Disord, 2008, 26(2): 161-164.

[22] Kimura R,Yamamotob M, Morihara T, et al. SORL1 is genetically associated with Alzheimer disease in a Japanese population[J]. Neurosci Lett, 2009, 461(2): 177-180.

[23] Verkhratsky A, Kirehhoff F. NMDA receptors in glia[J]. Neuroscientist, 2007, 13(1): 28-37.

[24] 江汉秋, 张晓君, 刘 瑾, 等. N-甲基-D-天冬氨酸受体2B基因(GRIN2B)启动子区多态性与散发性阿尔茨海默病的相关性分析[J]. 中国老年学杂志, 2010, 30(1): 1-4.

[25] Seripa D, Matera MG, Franceschi M, et al. Associa-tion analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease[J]. Dement Geriatr Cogn Disord, 2008, 25(3): 287-292.

[26] Mrak RE, Griffin WS. Glia and their cytokines in progres-sion of neurodegeneration[J]. Neurobiol Aging, 2005, 26(3): 349-354.

[27] Collins JS, Perry RT, Watson B Jr, et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset alzheimer disease: the NIMH Alzheimer disease genetics initiative[J]. Am J Med Genet, 2000, 96(6): 823- 830.

[28] Tarkowski E, Liljeroth AM, Nilsson A, et al. TNF gene polymorphism and its relation to intracerebral produc-tion of TNF alpha and TNF beta in AD[J]. Neurology, 2000, 54(11): 2077-2081.

[29] Blasko I, Marx F, Steiner E, et al. TNF alpha plus IFN gamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs[J]. FASEB J, 1999, 13(1): 63-68.

[30] Di Bona D, Candore G, Franceschi C, et al. Sys-tematic review by meta-analyses on the possible role of TNF-α polymorphisms in association with Alzheimer¢s dis-ease[J]. Brain Res Rev, 2009, 61(2): 60-68.